Leiomyosarcoma_NN
of_IN
the_DT
vulva_NN
:_:
report_NN
of_IN
a_DT
case_NN
._.

A_DT
52-year-old_JJ
female_NN
presented_VBD
with_IN
a_DT
progressively_RB
enlarging_VBG
vulvar_JJ
mass_NN
._.

Pathological_JJ
evaluation_NN
revealed_VBD
a_DT
high-grade_JJ
vulvar_JJ
leiomyosarcoma_NN
._.

Immunohistochemical_JJ
and_CC
ultrastructural_JJ
studies_NNS
were_VBD
performed_VBN
to_TO
support_VB
the_DT
diagnosis_NN
._.

In_IN
an_DT
effort_NN
to_TO
better_RBR
understand_VB
the_DT
biology_NN
of_IN
this_DT
tumor_NN
additional_JJ
immunohistochemical_JJ
studies_NNS
for_IN
the_DT
protein_NN
product_NN
of_IN
p53_NN
tumor_NN
suppressor_NN
gene_NN
and_CC
estrogen_NN
receptor_NN
expression_NN
by_IN
tumor_NN
cells_NNS
,_,
as_RB
well_RB
as_IN
the_DT
type_NN
of_IN
immune_JJ
cells_NNS
infiltrating_VBG
the_DT
tumor_NN
were_VBD
performed_VBN
._.

Tumor_NN
cells_NNS
showed_VBD
an_DT
overexpression_NN
of_IN
p53_NN
protein_NN
and_CC
were_VBD
estrogen_NN
receptor-positive_JJ
._.

Macrophages_NNS
and_CC
T_NN
and_CC
B_NN
lymphocytes_NNS
infiltrated_VBD
the_DT
tumor_NN
in_IN
moderate_JJ
numbers_NNS
with_IN
occasional_JJ
lymphoid_JJ
aggregate_NN
formation_NN
._.

This_DT
study_NN
is_VBZ
the_DT
first_JJ
attempt_NN
to_TO
better_RBR
understand_VB
the_DT
biology_NN
of_IN
these_DT
tumors_NNS
._.

